Chances are you’ve seen his recent studies that have highly contributed to the electronic cigarette industry. Dr. Konstantinos Farsalinos, a cardiologist, working as a researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. Over the past 2 years, he has been actively performing research on electronic cigarettes, at clinical and laboratory levels.
Recently, Dr. Farsalinos conducted the first ever study on e-cigarette vapor cytotoxicity potential on cultured cells. This study has been published (see link below). He has also performed the largest international Internet survey of e-cigarette users, with more than 19,000 participants – and growing – (results not yet published as the study remains open for participation through June 25). For the second consecutive time, he has received invitation to present results of his clinical research at the European Society of Cardiology annual Congress this year. The first presentation (2012 Congress) can be seen here:
AEMSA (American E-Liquid Manufacturing Standards Association) has added Dr. Konstantinos Farsalinos as a subject matter expert member (SME).
We welcome Dr. Farsalinos’ and look forward to his active participation in AEMSA! As we begin the complex process of refining our Standards for the 2013 version, Dr. Farsalinos’ involvement will complement and enhance the input from our other highly credentialed Organic Chemist SMEs. Dr. Farsalinos’ involvement will greatly facilitate our goals of Consumer Protectionism, Product Stewardship and Medical/Science based advocacy for refillable e-liquid products and Tobacco Harm Reduction.